Veye (Aidence) vs Cleerly Coronary AI (Cleerly Platform)
AI-enhanced independent comparison — features, pros, cons, pricing and rankings.
| Dimension | Veye (Aidence) | Cleerly Coronary AI (Cleerly Platform) |
|---|---|---|
| Accuracy & Reliability | ||
| Ease of Use | ||
| Features & Capability | ||
| Value for Money | ||
| Performance & Speed | ||
| Popularity & Adoption |
Who each tool serves best — and when to pick the other one.
Radiologists and healthcare providers focused on lung cancer screening and monitoring lung nodules in CT scans.
- You need accurate lung nodule detection from chest CT scans to support diagnosis
- You want automated volumetric analysis to track nodule changes over time
- Your team requires integration into existing radiology workflows for efficiency
Clinics without CT imaging infrastructure or those needing broader diagnostic AI tools beyond lung nodules.
- You need AI tools for diagnoses beyond lung nodules or chest CT scans
- Free-tier limits are a blocker for your clinical volume or feature needs
- You require extensive API access or custom integrations not provided
The tool’s ability to automate volumetric analysis of lung nodules for precise monitoring.
Cardiologists and radiologists seeking objective, detailed coronary artery disease analysis integrated into clinical workflows.
- You need precise quantification of coronary artery disease from CT scans for clinical decisions.
- You want to integrate advanced imaging analysis seamlessly into existing cardiology workflows.
- Your team requires reproducible and objective coronary artery disease visualization for treatment planning.
Healthcare providers without access to coronary CT angiograms or those needing broad diagnostic imaging beyond coronary artery disease.
- You need AI tools for general medical imaging beyond coronary artery disease.
- Free-tier limits are a blocker for your clinical volume or feature needs.
- You require public API access for custom integrations or automation.
Accuracy and clinical integration for coronary artery disease quantification from CT angiograms.
A canonical comparison across capabilities common to this category. Vendor-specific extras appear below in "Highlighted Features".
| Capability | Veye (Aidence) | Cleerly Coronary AI (Cleerly Platform) |
|---|---|---|
|
Free Tier Available
Usable without payment (with usage limits)
|
✓ | ✓ |
Each tool's marketing-listed features. Where a feature appears under one tool but not the other, it usually reflects how the vendor describes their product — not a definitive capability gap.
- Lung Nodule Detection — Detects lung nodules from chest CT scans
- Volumetric Analysis — Automated volumetric measurement of nodules over time
- Workflow Integration — Seamless integration with radiology diagnostic workflows
- Reporting Tools — Generates reports to support clinical decision-making
- User Interface — Intuitive UI designed for radiologists
- Coronary CT Angiogram Analysis — Quantifies and visualizes coronary artery disease severity
- Clinical workflow integration — Integrates with cardiology and radiology clinical workflows
- Objective Disease Quantification — Provides reproducible and objective insights for diagnosis
- Visualization tools — Visualizes artery disease severity in detail
- Advanced Reporting — Generates detailed reports for clinical decision support
- Automated volumetric analysis for precise lung nodule tracking
- Integrates smoothly into existing diagnostic workflows
- Supports early lung cancer detection with high accuracy
- User-friendly interface tailored for radiologists
- Reduces manual workload in lung nodule assessment
- Accurate and reproducible coronary artery disease quantification
- Clear visualization of artery disease severity
- Seamless integration with clinical workflows
- Designed specifically for cardiology and radiology professionals
- Supports improved diagnosis and treatment planning
- Limited to lung nodule detection in chest CT scans
- Pricing and feature tiers are not fully transparent publicly
- No public API or mobile app available
- Limited publicly available pricing details
- No public API for custom integrations
- Focused solely on coronary artery disease, not broader imaging
- Early lung cancer screening and detection
- Monitoring lung nodule growth over time
- Supporting radiologists in chest CT scan analysis
- Improving diagnostic workflow efficiency
- Generating clinical reports for lung nodules
- Quantifying coronary artery disease severity from CT scans
- Supporting cardiologists in diagnosis and treatment planning
- Enhancing radiology workflow with automated analysis
- Visualizing artery disease for patient consultations
- Improving reproducibility in coronary imaging assessments
No third-party integrations confirmed.
Natural languages each tool generates and understands. Primary languages are listed first.
What each tool can accept (input) and produce (output) — text, image, audio, video, code.
Offers a freemium model with a free plan and paid subscriptions for advanced features; exact pricing details are not publicly disclosed.
-
Free
Free
Offers a freemium pricing model with basic features available for free; advanced capabilities and higher usage may require paid plans.
-
Free
Free
Regulatory frameworks each tool claims compliance with (HIPAA, SOC 2, GDPR, etc.).
Third-party audits and certifications that verify security controls.
No certifications listed.
Vendor-published numbers each tool highlights — usage scale, breadth, and operational stats. Different tools track different metrics, so direct row-by-row comparison usually isn't meaningful.
- Accuracy Improvement High
- Accuracy High precision in coronary artery disease quantifi
- Integration Seamless clinical workflow compatibility
How you can reach support — email, live chat, phone, community, docs.
- Email primary
- Email primary
How each tool is classified in the Volvenix catalog.
These vocabulary domains are managed in our catalog but not yet exposed at the tool level. We're tracking them for future expansion of this comparison.
- Encryption Types — AES-256, ChaCha20, RSA-2048, and similar at-rest/in-transit cipher families.
- Encryption Contexts — where encryption is applied (data at rest, in transit, end-to-end).
- Plan-tier Model Mapping — which AI models are available on which pricing tier (currently only the model list is tracked, not the per-plan availability).
- What is this tool?
- Veye detects and quantifies lung nodules from chest CT scans to assist radiologists in early lung cancer detection.
- How much does it cost?
- Veye offers a freemium pricing model with a free plan; detailed paid pricing is available upon request.
- Does it have a free plan?
- Yes, Veye provides a free plan with basic lung nodule detection features.
- What integrations does it support?
- Veye integrates into radiology diagnostic workflows but does not publicly list third-party software integrations.
- Who is it best for?
- It is best suited for radiologists and healthcare providers focused on lung cancer screening using chest CT scans.
- What is this tool?
- Cleerly Coronary AI analyzes coronary CT angiograms to quantify and visualize coronary artery disease severity for clinical use.
- How much does it cost?
- Cleerly offers a freemium pricing model with basic features free; advanced features may require paid plans.
- Does it have a free plan?
- Yes, a free plan is available with basic coronary CT scan analysis features.
- What integrations does it support?
- It integrates with clinical cardiology and radiology workflows; no public API or third-party integrations are documented.
- Who is it best for?
- It is best suited for cardiologists and radiologists needing objective coronary artery disease analysis.
| Info | Veye (Aidence) | Cleerly Coronary AI (Cleerly Platform) |
|---|---|---|
| Pricing | Freemium | Freemium |
| Category | Healthcare & Medical AI | Healthcare & Medical AI |
| Deployment | Cloud | Cloud |
| Free Plan | ✓ | ✓ |
| AI Agent | ✗ | ✗ |
| Autonomy | Assistant | Assistant |
| Risk Tier | Medium | Medium |
Cleerly Coronary AI (Cleerly Platform) and Veye (Aidence) both offer freemium pricing models, allowing users to access basic features at no cost with options for paid upgrades. Cleerly focuses primarily on coronary artery disease analysis using AI to assess plaque and stenosis from cardiac CT scans, targeting cardiology diagnostics. Veye, on the other hand, specializes in lung nodule detection and management through AI-enhanced analysis of chest CT scans, aimed at pulmonary care. While Cleerly has an overall score of 5.5/10, Veye scores slightly higher at 5.7/10, reflecting minor differences in user satisfaction or feature sets related to their distinct clinical applications.
ⓘ How Volvenix scores work
Scores are computed by Volvenix — not supplied by the vendors, and not third-party benchmark results. Each 0–10 dimension (Overall, Features, Usability, Support, Pricing) is a directional estimate aggregated from catalog signals — editorial cataloguing, content depth, engagement, and provider-reputation indicators — so treat them as a starting point, not a lab result.
Confidence reflects how complete the underlying data is for both tools; lower confidence means fewer signals were available, not a worse tool. We never accept payment for rankings or scores. More about how Volvenix works →